Loss of smell can occur for numerous reasons including nasal or sinus infection, chemical exposure and pollutants, dental problems, medication use, chronic conditions such as diabetes and hypertension, traumatic brain injury, neurodegenerative diseases such as Parkinson’s disease, or normal aging (Doty, 2019). A partial loss of smell (hyposmia) or a complete loss of smell (anosmia) detrimentally impacts quality of life (i.e., loss of favored smells associated with food, activities, and sex), poses a safety risk (i.e., eating spoiled foods, unable to detect harmful fumes), and can be debilitating for people, especially those who rely on this sensory ability in their professional lives (i.e., natural gas workers, chefs, perfumers). In the National Social Life, Health, and Aging Project, a 15-year longitudinal study of older adults, Eliyan et al. (2020) found that baseline olfactory impairments predicted depression 5–10 years later. In the same study, Pinto et al. (2014) discovered that olfactory impairment significantly predicted 5-year mortality (OR = 3.37).

Interestingly, declining olfaction and olfactory impairment serve as a bellwether for the development of cognitive impairment and neurodegenerative diseases. In a meta-analysis of 12 articles examining olfactory function (e.g., odor identification, odor discrimination, or odor detection threshold) including 788 patients with mild cognitive impairment (MCI) and 563 patients with Alzheimer’s disease (AD), Jung et al. (2019) found that olfactory impairment, specifically odor identification, was more profound in those with AD. This finding suggests that a simple odor identification test may discriminate between MCI and AD. Similarly, in a meta-analysis of 31 articles examining olfactory function in 1,993 MCI patients and 2,861 cognitively healthy older adults, Roalf et al. (2017) found that olfactory impairment, specifically odor identification, was more severe in those with MCI. This bellwether effect is observed in other health conditions as well. In fact, many studies reported the association between olfactory impairment and corresponding cognitive impairments in normal middle-aged and older adults (Adams et al., 2018; Devanand, 2016; Woodward et al., 2017, 2018). Studies have also reported that poor olfaction in cognitively normal older adults is associated with future risk of dementia at longitudinal follow-up (Devanand et al., 2015; Schubert et al., 2008; Yaffe et al., 2017). These studies suggest a potentially strong neurological connection between olfaction and cognition.

Unlike the other sensory systems that are gated through the thalamus, the peripheral olfactory system extends neuronal projections directly to cortical areas that support cognition such as the orbitofrontal cortex, amygdala, pyriform cortex, and entorhinal cortex (Leon & Woo, 2018; See Fig. 1). Remarkably, compromised olfaction or a loss of olfaction corresponds to volume loss in the same brain regions (Leon & Woo, 2018; Yao et al., 2014). Olfaction and localized loss of brain volume show a parallel vulnerability to deterioration with age (Kollndorfer et al., 2015; Segura et al., 2013).

Fig. 1
figure 1

Overview of olfactory training and olfactory system connections

An extensive literature clearly demonstrates that intentional odorant delivery can negatively or positively impact cognitive function (Johnson, 2011). In a classic study, Rotton (1983) found that exposure to a malodor (ethanethiol) negatively affected proofreading (a complex task) but not basic arithmetic (a simple task). Others have found that exposure to commercially available essential oils in real-time can improve memory, alertness, vigilance, self-perception, pain perception, and mood (Johnson, 2011). Similarly, Tsushima et al. (2021) found that exposure to a lemon odorant and vanilla odorant modulated positively and negatively, respectively, low-level visual perception, which suggests some innate characteristics of odorants on perception and cognitive function.

Following this reasoning, neuroplastic processes may be upregulated through olfactory stimulation; such olfactory stimulation provides novelty and adaptation, thus potentially supporting cognitive function. In several studies, more stimulating environments, across factors such as occupational complexity, diverse work histories (Carr et al., 2020), exposure and mastery of another language (Bialystok et al., 2004; Kuhl et al., 2016), or engaging in challenging activities such as computerized cognitive training (Lampit et al., 2014), can improve cognition and change brain morphology. It is well accepted that enriched environments may enhance cognitive reserve, which protects one from cognitive decline and dementia (Vance et al., 2019). It has been hypothesized that sensory stimulation, such as olfactory training (OT; a.k.a., smell training), could upregulate neuroplastic processes to improve cognition, brain connectivity, and brain health (Leon & Woo, 2018).

When we consider the positive role of sensory stimulation (i.e., visual, auditory, tactile, gustatory, and olfactory) or the negative role of sensory deprivation or impairment of sensory abilities, the potential impact on neuroplasticity becomes apparent (Leon & Woo, 2018). Moreover, in a sample of 3,005 community-dwelling older adults, Pinto et al. (2017) found that global sensory impairment in all five senses at baseline independently predicted decreased physical and cognitive function and increased significant weight loss and mortality five years later. Based on the Common Cause Hypothesis, the rate at which our sensory abilities decline parallels that of cognitive declines (Dulay & Murphy, 2002; Uchida et al., 2019). In the Victoria Longitudinal Study of Aging (N = 408), MacDonald et al. (2018) observed that olfaction, surprisingly more than vision and hearing, was predictive of cognitive decline; others have found similar associations between olfaction and cognition (Dulay & Murphy, 2002). Importantly, studies have demonstrated cognition improved once hearing (Brewster et al., 2021; Uchida et al., 2019), vision (Pellegrini et al., 2020; Varadaraj et al., 2021), and olfaction (Birte-Antina et al., 2018) are improved via mechanical devices (i.e., hearing aids; Knopke & Olze, 2018), surgery (i.e., cataract surgery; Kheirkhan et al., 2018), or OT (Birte-Antina et al., 2018; Knudsen et al., 2015), respectively. Yet, the extent of this association has not been well assessed in the case of OT.

Given the connection between olfaction and cognition, does OT improve cognition and alter brain structure and connectivity? In other words, does peripheral stimulation of the olfactory system (smelling odorants through OT) produce changes in cognition and brain morphology or function. In this systematic review, we addressed this question by surveying the extant literature systematically and documenting whether OT improves cognition, or brain resources (i.e., morphology, function, connectivity) that support cognition. Second, the identified articles (N = 18) were briefly summarized (Appendix 1). Third, a synthesis of these articles was conducted. Finally, implications for practice and future research directions were discussed.

Methodology of Systematic Review

Using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) approach (Moher et al., 2009), on January 19, 2022, MEDLINE (via PubMed), Embase, and Scopus databases were searched for research studies on any type of OT tested in humans, of which cognitive or brain neuroimaging outcome data were gathered and reported (Fig. 2); a year restriction was not imposed. Search terms are provided in Table 1. From this, 1,015 records were identified and 82 duplicates were removed, leaving 933 records to be reviewed. An additional search was conducted in September 7, 2022 to include newer publications not captured from the original January search. The search update resulted in 66 new records, of which 0 were deemed relevant to be included in the final review. Using the Covidence software, two of the authors (DEV & JSF) reviewed these article titles, abstracts, and articles separately to determine whether the article met study inclusion criteria. They then compared their findings and discussed each one until consensus was met on whether the article met the criteria.

Fig. 2
figure 2

PRISMA diagram demonstrating screening method for literature search

Table 1 Terms used to search for targeted articles in PubMed, Embase and Scopus (Syntax Language)

More precisely, the articles (in English) were evaluated for the following inclusion criteria: 1) original research studies in adult humans (not systematic reviews, review articles, or case reports); 2) examination of any standard OT (repeated odorant exposure) occurring over multiple sessions; 3) experimental study design with a clear baseline and posttest follow-up assessment; 4) olfaction measured at least at baseline; and 5) neuronal (e.g., MRI, EEG brain neuroimaging, cerebral blood flow, neurotropic factors) or cognitive (e.g., cognitive testing) outcomes must had been assessed at least at baseline and at one follow-up assessment. Studies that did not meet all five inclusion criteria were excluded.

OT Intervention Studies

As a level 1a evidence supported therapy, OT is considered as an effective approach to restore or improve olfaction (Patel, 2017). Despite the large number of OT studies, OT studies that include cognitive or neural (e.g., brain neuroimaging) outcomes have only recently becoming more common. For the purposes of this review, it is important to highlight the basic structure of most OT protocols found in the literature; however, there is a great deal of variability in how OT is delivered. OT studies have four essential elements: 1) participant selection, 2) targeted outcomes, 3) intervention components, and 4) treatment adherence. First, many studies targeted participants with objective or subjective olfactory impairment or those vulnerable for developing such impairment (e.g., older adults); however, some studies attempted to improve olfaction in normosmic participants. Second, subjective olfaction is measured by self-reported ability to smell (e.g., smell complaints, ability to smell) while several aspects of objective olfaction are often reported including: a) odor detection threshold (i.e., detecting an odorant among three odorant pens with the other two pens containing an odorless solvent), b) odor discrimination (i.e., being able to discriminate the unique odorant from otherwise a choice of identical odorants), and c) odor identification tests (i.e., smelling an odorant and identifying it from a list of four descriptors). In fact, many studies combine these three measures to form a composite score referred to as TDI (i.e., odor detection Threshold, odor Discrimination, and odor Identification). Third, OT entails exposure to various odorants on a regular basis and consists of the following parameters: a) delivery vehicle, b) odorants, and c) dosage. The delivery vehicle varies from study to study but typically has odorants of various concentrations placed in small capsules or bottles in which the cap is removed for the participant to sniff. In earlier human studies with OT, the odorants and their concentrations were of approximately equal and moderately perceived intensity (Livermore & Laing, 1996). Odorants typically consist of four primary types considered to be representative across the “odor prism” including: a) flowery (e.g., rose), b) resinous (e.g., eucalyptus), c) aromatic (e.g., cloves), and d) fruity (e.g., lemon); however, some studies may actually have as many as 12 odorants (e.g., Altundag et al., 2015) or vary the odorants between single-molecule to complex-molecule odorants or “light weight molecules” versus “heavy weight molecules” (e.g., Poletti et al., 2017). Dosage varies greatly but generally consists of smelling each odorant for 10–20 s at a time, 2x/day over a period of 8–35 weeks. Finally, concerning adherence, treatment adherence is commonly assessed via a daily diary with results collected at the end of training (e.g., Birte-Antina et al., 2018; Knolldorfer et al., 2015; Negoias et al., 2017; Pellegrino et al., 2019). Most of the studies reviewed in this article used the Sniffin’ Sticks test for olfactory assessment and otherwise conformed to the above parameters (Hummel et al., 1997).

Results

From this systematic review, the 18 studies reviewed are summarized in Appendix 1 and displayed in Tables 2 and 3. The detailed article summarizes are categorized in chronological order (oldest to recent) and by outcome variable of OT: 1) cognitive studies, 2) neuroimaging studies, 3) cognitive and neuroimaging studies, and 4) other.

Table 2 Summary of olfactory training studies on cognition and brain Structure/Function/Connectivity (N = 18) (Syntax Language)
Table 3 Concise summary and comparison of OT studies with a Pre/Post experimental design (N = 18)

Cognition was assessed in five of the studies with limited sample sizes ranging from 33–91 participants, and with a limited cognitive battery, except for Cha et al. (2022) which had nine cognitive tests. Across all five studies, there is convergent findings that indicate OT in adults with and without olfactory loss at baseline can cognitively benefit from OT; albeit, for Chen et al. (2022), these results were mixed as the control group also experienced some cognitive improvements. Such cognitive benefit was observed in as little as 15 days in adults with dementia and as much as 6 months in healthy older adults. Cognitive benefits were observed in global cognition as well as the domains of verbal fluency, verbal learning and memory, and attention. In fact, four of these studies either had a no-contact control group or a more rigorous active (i.e., Suduko) control group or a sham OT group. Interestingly, a comparison in the dosage (2x/day versus 4x/day) suggests that a moderate dosage may be more effective than a higher dosage of OT. In general, the dosage of 2x/day of 4 or more odorants for 12 to 24 weeks was sufficient to produce these cognitive effects.

Neuroimaging was assessed in 13 of the studies that met the criteria for this systematic review. Most of the studies had small to moderate samples sizes (N’s = 7, 7, 11, 16, 25, 33, 36, 36, 37, 54, 58, 61, 97) for neuroimaging studies with a pre/post experimental design. First, four out of five studies that examined volume change in the olfactory bulb confirmed that OT (ranging from 16–24 weeks of OT dosage) resulted in an increased olfactory bulb volume, and this was observed across normosmic, hyposmic, and anosmic groups. Second, in the five studies that examined brain volume, all of them reported on increased volume after OT in several regions of interest including the cerebellum, thalamus, frontal cortex (i.e., right superior, right medial orbital), right gyrus rectus, right supplementary motor area, left precuneus, left superior medial cortex, left midcingulate cortex, hippocampus, and right insular, regions suggested to be involved with olfactory memory and verbal ability. These volume changes were observed after 6 weeks to 7 months of OT. Third, all six studies that examined brain connectivity confirmed that OT (ranging from 12–24 weeks of OT dosage) resulted in increased brain connectivity (or efficiency), and this was also observed across normosmic, hyposmic, and anosmic groups. In particular, such increased activation was observed in the dorsal anterior cingulate, several left hemisphere structures, orbitofrontal cortex, cingulate cortex to the insula, frontal lobe, and left parietal occipital juncture. Collectively, these neuroimaging studies indicated that various populations with or without olfactory loss experienced positive neuroplastic changes in the brain resulting from OT.

Beyond cognition and neuroimaging, only one study measured electro-physiological responses at the level of the olfactory epithelium. Hummel et al. (2018) observed in ansomics and hyposmics that OT was associated with a significantly higher number of electro-olfactogram responses.

Synthesis of Methodology of OT Studies

Methodologically, these OT studies have distinct and overlapping features that influence the quality of the data and the conclusions derived from them. Such features include the adequacy of control group(s), sample size and participant characteristics, treatment dosage, treatment adherence, length of follow-up, olfactory confounds, the inclusion of cognitive assessment and other neural measures.

Control Group Adequacy

Most (n = 10) of the reviewed studies used a one-group pre-post experimental design with no control group. The lack of a control group is considered a limitation as any type of participant engagement can exert an unknown influence on the dependent variables (i.e., cognition and brain changes). When a control group receives as much contact/engagement as the experimental group, the ability to derive causation improves. Yet the other eight studies had a variety of comparison groups such as comparing two OT dosages (Oleszkiewcz et al., 2022), comparing simple odorants to more complex mixture odorant OT (Oleszkiewcz et al., 2022), or comparing the OT to an active group (i.e., Sudoku group; Birte-Antina et al., 2018), or a standard no-contact control group (Oleszkiewcz et al., 2022). With OT in particular, developing an appropriate contact control condition remains a challenge. One could use non-scented stimuli as a sham condition, but the lack of an odorant may result in disinterest and poor adherence. However, Chen et al. (2022) did have an OT control group that was instructed to sniff bottles with no odorants. Even a control condition with only weak scents could be a confound as even an undetectable odor threshold could have an unknown impact on treatment outcomes as observed in Oleszkiewicz et al. (2021). Clearly, most of the reviewed articles were pilot studies with limited resources; thus, the choice of no active control group or no-contact control group was likely a financial one. The lack of an adequate control group represents a major criticism of this OT literature.

Sample Size and Attrition

As noted above, the reviewed OT studies appear to be predominantly pilot/feasibility studies; as such they were limited by small sample sizes that reduced their generalizability, power, and ecological validity. Albeit, many of these studies found a statistically significant therapeutic improvement in olfaction, cognition, and brain function, suggesting that these approaches are robust. Surprisingly, attrition was rarely reported, which is curious with a daily treatment protocol that requires 12–24 weeks to complete. Clearly, an intervention that requires engagement at least 2x/day would seem to be a burden that would affect attrition. Moving forward, the science of OT requires more rigor regarding treatment adherence, attrition, and larger sample sizes to ensure the generalizability of the findings, especially in different clinical populations that may have various olfactory and neurological risk factors.

Treatment Dosage

Dosage in OT studies is normally reported in the number of times per day participants are engaged in smelling the odorants over a period of time; typically, this is four odorants for 10–20 s each 2x/day (morning & evening) usually administered over 12–24 weeks. Oleszkiewicz et al. (2022) delved into the issue of dosage by comparing the effectiveness of training 2x/day versus 4x/day. Likewise, it is not clear in the OT literature presented why there is a focus on only four odorants; Oleszkiewicz et al. (2022) is the only OT where five odorants were used, and then replaced later with an additional five new odorants or in a separate study, Oleszkiewicz et al. (2022) used nine odorants in the OT. In fact, Altundag et al. (2015) modified OT by allowing participants to use three sets of four odorants sequentially after 12 and 24 weeks and found it to enhance the effectiveness of OT compared to the standard four odorants. Conceptually from a neuroplasticity perspective, it seems that providing more odorants would provide more novel stimulation that could improve olfaction and produce more robust cognitive outcomes (Vance et al., 2012).

Furthermore, since most of the studies with only 12 weeks of OT did not include cognitive measures, it is not clear whether this time frame is sufficient to produce a neuroplastic change reflective of cognitive improvement. However, olfactory bulb volume increases, structural volume increases, and functional connectivity changes were found after 12 weeks of training; this suggests that this time frame is sufficient to stimulate neuroplastic changes that could simultaneously support cognitive function.

Treatment Adherence

Most studies reported a diary or journal method to measure adherence. Unfortunately, few studies described this in detail and some studies failed to report their adherence data. Self-report of treatment adherence is subject to recall bias or social desirability. Some studies reported perfect adherence, but it seems unlikely from a practical standpoint that all participants were perfectly adherent to a protocol that requires twice daily engagement. Yet, since Al Aïn et al. (2019) conducted the OT in the laboratory with participants, they were the only ones to be able to have strong adherence data. Moving the OT literature forward, it is essential to apply more rigorous methods to quantify treatment adherence and incorporate adherence data into the data analysis. Without stronger adherence data, the findings of OT will be suspect, especially in being able to examine dosage responses.

Length of Follow-up

Although these studies do have substantial length of training of up to seven months, most lacked follow-up after training completion. Thus, it is not clear how robust the training effects on olfaction or cognitive/brain function outcomes would be following OT cessation. As a parallel example, in the ACTIVE Study, durability of the speed of processing training over 2–10 years was observed in sustained improvement of speed of processing and other areas (i.e., dementia risk, driving safety) (Edwards et al., 2017; Ross et al., 2016, 2017). Unfortunately, no such follow-up is available in these OT studies. Thus, it is important to document the durability of the OT effects as this determines its long-term effects for patients.

Olfactory Confounds

A potential confound that could impact both OT and olfactory assessment is exposure to other odorants in one’s environment. Eating aromatic foods, using colognes and scented hygiene products, lifestyle (i.e., smoking), and exposure to household odorants (i.e., incense, scented candles) could potentially impact one’s sense of smell which could impact the delivery of OT and olfactory assessment. Few studies control for this. For example, in a study of olfaction in 51 adults with HIV, Vance et al. (2020) specified in their appointment letter and in a checklist at the time of the study visit that participants should refrain from eating spicy or aromatic foods the night before and morning of their testing visit as this could interfere with the quality of the data. In our current systematic review, only one of the OT studies (i.e., Oleszkiewicz et al., 2022) specifically instructed participants not to engage in the OT 30 min before or after meals as this could potentially interfere with the intervention. Moving forward, to further the rigor in OT, it is essential to consider whether such natural daily exposures to odorants in the environment are negligible to OT or whether this is an important variable to control.

Cognitive Assessment and Neuroimaging Markers

Only a limited cognitive battery was administered when cognitive measures were included in these OT studies. The inclusion of a complete cognitive battery, representing a range of cognitive domains including attention, speed of processing, verbal learning and memory, visuospatial learning and memory, and executive functioning, would allow a more comprehensive examination of the impact of OT on cognitive functioning. It is likely that OT could potentially impact several cognitive domains.

Furthermore, only one of the reviewed OT studies included both cognitive and neuroimaging measures (Chen et al., 2022). Thus, it is difficult to determine the corresponding neural correlates of OT-induced cognitive improvement. The rigor of future studies could be substantially improved by assessing cognition while acquiring multimodal neurophysiological data (structural MRI, fMRI, diffusion tensor imaging, EEG/ERP, neuronal biomarkers) in the same participants. In fact, as cognitive training and other types of cognitive rehabilitation has been shown to increase neuronal biomarkers such as Brain-Derived Neurotropic Factor (e.g., Angelucci et al., 2015), such markers of neurological improvement may be salient in OT studies.

Discussion

In our review of OT studies, we found that OT improved olfaction over baseline performance in those with and without olfaction loss. In general, this olfactory improvement was associated with improved cognition and changes in neurological structures and connections. Specifically, these changes included: 1) improved cognition (i.e., verbal fluency, memory, global cognition Birte-Antina et al., 2018; Knudsen et al., 2015; Oleszkiewicz et al., 2021; Oleszkiewicz et al., 2022); 2) increased olfactory bulb volume (Gellrich et al., 2018; Mahmut et al., 2020; Negoias et al., 2017); 3) increased volume in hippocampal, cerebellum, and thalamic regions (Gellrich et al., 2018); 4) increased neural signal activity (Kollndorfer et al., 2015); 5) greater functional connectivity in the chemosensory processing networks (Kollndorfer et al., 2015); 6) new activation in the right dorsal anterior cingulate (Pellegrino et al., 2019); 7) increased activation in several left frontal areas associated with language (Pellegrino et al., 2019); and 8) increased response amplitude of the olfactory epithelium (Hummel et al., 2018)..

Theories of OT and Cognition

In the context of olfactory loss, prior research has found grey matter volume decreases in the anterior cingulate cortex and insula, as well as the cerebellum (Bitter et al., 2010; Reichert & Schöpf, 2018). The anterior cingulate cortex is associated with executive functioning (Devinsky et al., 1995), particularly conflict monitoring (Botvinick et al., 2004). In addition to being linked with the gustatory cortex, the insula has also been associated with emotion and cognition (Gasquoine, 2014) though the integration of different functional systems that are involved in sensory-motor processing, affect, and cognition, including language and attention (Chang et al., 2013; Uddin et al., 2017). Moreover, both the anterior cingulate cortex and insula have been associated with olfaction in fMRI studies and increased blood-oxygen-level-dependent (BOLD) activation has been observed in the cerebellum in response to olfactory stimulation (Albrecht et al., 2010; Ferdon & Murphy, 2003; Savic, 2002; Wabnegger & Schienle, 2019). The cerebellum is involved in more than just motor control, with the posterior lobe of the cerebellum linked with numerous cognitive functions, including working memory, planning/organization, strategy development, verbal fluency, and error awareness (Schmahmann, 2019). Individuals with complete anosmia also show less activation in the dorsolateral prefrontal cortex (Iannilli et al., 2011), a region associated with cognitive control and working memory (Andrews et al., 2011; MacDonald et al., 2000). Additionally, there is a direct link between olfactory processing and the hippocampus and entorhinal cortex (Biella & De Curtis, 2000; Kubota et al., 2020; Rai et al., 2021; Vanderwolf, 1992). Indeed, it has been hypothesized that disruption of olfactory-entorhinal cortex-hippocampus circuitry upregulates memory decline (Daulatzai, 2015).

With these associations of olfactory loss and functional and structural neural correlates in regions associated with attention, language, memory, and higher-order executive functioning, it is not surprising that olfactory and cognitive declines are associated. Moreover, the link between neurological illnesses (i.e., Parkinson’s disease, Alzheimer’s dementia, frontotemporal dementia, & epilepsy) and anosmia also makes conceptual sense (Doty, 2012; Kamath et al., 2019; Khurshid et al., 2019; Kulason et al., 2021).

Is it possible to improve olfaction, cognition, and neural processing though OT? Regarding the link between olfaction and grey matter volume, there is growing evidence that OT not only improves olfaction but also yields increased grey matter volume in multiple critical regions such as the hippocampus and entorhinal cortex, inferior, middle, and superior frontal gyri, and the cerebellum (Al Aïn et al., 2019; Rezaeyan et al., 2022). While there is a paucity of research examining how cognition is affected by OT, based on these MRI volume findings, we can hypothesize that attention, memory, and executive functioning abilities should improve post-OT. Pulling from the traumatic brain injury literature, the spontaneous return of olfactory functioning, as well as improved olfaction following OT, has been associated with both an increase in olfactory bulb volume, attributed to increased glomerular dopaminergic interneurons, as well as increased subventricular neurogenesis (Marin et al., 2020). There appears to be lifelong neurogenesis in the subventricular zone, which is found in the lateral ventricles, and in adults, this migrates anteriorly into the olfactory bulb (Lim & Alvarez-Buylla, 2016). It is possible that OT stimulates the subventricular zone, thus increasing the number of interneurons and the olfactory bulb volume. Given the afferent and efferent projections between the olfactory bulb and the above-mentioned neuroanatomical regions, neuroplastic changes likely result in increased grey matter volume in multiple brain regions. We speculate that this will then translate to improved cognitive functioning.

Implications for Clinical Practice

Prior studies and systematic reviews indicate that OT is safe and can be used to improve olfaction in those with and without olfactory loss (Doty, 2019; Patel, 2017). Our systematic review provides further evidence that OT may provide both cognitive and neurological benefits. Given the inexpensive nature and safety of OT, clinicians can suggest its use to patients interested in trying this on their own. In fact, in participants with idiopathic and post-infectious olfactory loss, Patel et al. (2017) observed that OT that used random concentrations of essential oils was just as effective as standard OT with control concentrations; perhaps there would be a cognitive or neurological benefit as well. Albeit, patients should be warned that the efficacy of OT on cognitive and neurological outcomes has not been firmly established, nor has the type of delivery protocol, types of odorants, or dosage of OT been clinically defined to produce optimal therapeutic benefit. Thus, we assert that this article is not an endorsement for people to buy essential oils or other odorants with the expectation that it is a “cure all” for everything from improved sensory acuity to preventing Alzheimer’s disease. Substantially more research in both healthy and various clinical populations is needed before OT can be empirically supported.

Implications for Research

There are several implications from this systematic review which provide future directions on OT as a potential neurocognitive therapeutic tool, many of which are already highlighted in the synthesis section above. First, to more comprehensively quantify olfaction, studies should measure odor identification, odor detection threshold (below – Sniff Magnitude Test), and odor discrimination, and perhaps measures of olfactory-related ERPs which can provide more specific physiological data to olfaction (Gudziol & Guntinas-Lichius, 2019).

Second, fMRI and structural MRI should continue to be included in research designs to further expand our knowledge of the underlying neural mechanisms. While functional MRI can provide substantial information about the spatial resolution of neural processing and complement the high temporal resolution of olfactory-related ERPs, these measures currently lack clinical correlations in this literature. A task-based fMRI study can indicate that a specific cognitive ability is aberrant relative to a control group, but it is difficult to directly translate this to clinical practice. Therefore, neuroimaging and OT studies should also include baseline and post-training cognitive assessments. The direct measure of cognitive functioning will expand our understanding of underlying mechanisms and will help determine the added benefit of OT beyond improved olfaction.

Third, OT could be improved through applying methods from the multisensory literature. For example, speech perception in a noisy environment is improved in both healthy and clinical populations when auditory-verbal stimuli are paired together, rather than auditory-alone or visual-alone (Foxe et al., 2015; Ross et al., 2007). A similar approach can be taken with paired olfactory and visual sensory inputs. In an animal model targeting both the gustatory cortex and piriform olfactory cortex, there is evidence of multisensory integration, with optical inhibition of gustatory cortex neurons resulting in aberrant recognition of odor stimuli (Maier et al., 2015). In humans, visual objects that are associated with an odor are processed in the posterior piriform cortex, with activation in this region increasing when, more senses are providing congruent information (Porada et al., 2019), with both studies suggesting the piriform cortex is a crucial node in the olfactory multisensory network. Leveraging this multisensory relationship between olfaction and visual stimulation in OT protocols could potentially enhance efficacy on olfactory and cognitive outcomes.

Fourth, sex differences in olfaction have not been directly examined in OT but could be a useful variable to consider in future studies. In particular, a female advantage of olfaction has been attributed to the indirect influence of gonadal hormones, menstrual cycle-related fluctuations, and neuroendocrine influences on brain regions involved in olfactory processing (Doty & Cameron, 2009; Sorokowski et al., 2019). Social factors can also contribute as women generally experience greater olfactory awareness, odor familiarity, and greater exposure to odors in their social environment. In contrast, men experience a greater risk of toxic exposure to chemicals and hazards in their occupational environments. As odor identification tasks require assigning a verbal label to a retrieved odor memory, the enhanced verbal abilities observed in women may also explain these differences (Doty & Cameron, 2009; Sorokowski et al., 2019).

Fifth, as OT was conducted in older adults, healthy younger adults, those with traumatic brain injury, and with various levels of olfaction from normosmic to anosmic, this may be an intervention in other clinical populations vulnerable to both cognitive and olfactory deficits such as those with HIV, mild cognitive impairment, early-stage Alzheimer’s disease, and Parkinson’s disease (Vance & Brew, 2021). Due to the COVID-19 pandemic, chronic olfactory loss is a major growing public health concern, with consequences of anosmia including poor quality of life, inadequate nutritional intake, and increased risk of psychiatric conditions. It has recently been estimated that 700 K to 1.6 M persons living in the US will endure long-term smell dysfunction due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Khan et al., 2022). As COVID-19 is associated with deficits in olfaction and cognition, OT may be a potential therapeutic technique that addresses both olfaction and cognitive dysfunction (Vance et al., 2021).

Sixth, more study is needed to investigate the bottom-up and top-down processes involved with OT. These OT studies generally support the idea that OT, which involves stimulating olfactory epithelium and olfactory receptors peripherally, improves cognition and brain function; this represents a bottom-up process. Albeit, Negoias et al. (2017) observed that lateralized OT to either the right or left nostril of healthy people resulted in an olfactory bulb volume increase and improved olfactory detection thresholds in the untrained nostril; this indicates a top-down process. Future studies may also investigate whether improving cognition, via cognitive training or other such intervention methods, produces a top-down improvement in olfaction as well.

Seventh, another mechanism by which OT could improve cognition and brain function is through the enhancement of mood. For example, Birte-Antina et al. (2018) found that OT decreased depression. Odorants have been reported to enhance mood in general (Chen & Chen, 2015; Doty, 2019). Given the connection between mood, cognition, and brain function (Doty, 2019; Uddin et al., 2017), one hypothesis is that OT could improve mood which downstream improves cognition. Another possible pathway is through the insula, which is involved in cognitive processing and affect, and is also related to olfaction (Chang et al., 2013; Uddin et al., 2017). Diminished olfactory abilities in major depression are accompanied by corresponding changes in the peripheral and central olfactory system, including abnormalities in olfactory event-related potentials (OERPs), olfactory sulcal depth, olfactory bulb volume, and olfactory fMRI (Croy and Hummel, 2017; Negoias, et al., 2010; Pause et al., 2003; Rottstaedt et al., 2018a, b; Takahashi et al., 2016). Interestingly, performance on olfactory psychophysical testing, fMRI BOLD response to odorants, and OERPs improved with treatment in the form of psychotherapy and medication (Croy et al., 2017; Pause et al., 2003).

Eighth, if we can improve the effectiveness of OT, we may also be able to improve its cognitive and neurological impact. The literature suggests that an underlying inflammation of the paranasal sinus epithelium may be an unrecognized contributor to olfactory impairment, such that, treating sinonasal inflammatiion may also improve OT outcomes. Nguyen and Patel (2018) randomized 133 hyposmic patients without sinonasal inflammation into two groups. The experimental group received standard OT plus daily 2x/day self-administered nasal irrigation with budesonide, a steroid that reduces inflammation. The control group also received standard OT but was irrigated with saline. Analysis revealed that 43.9% of the experimental group (OT + budesonide irrigation) and 26.9% of the control group (OT + saline irrigation) experienced a clinically significant change in smell identification (i.e., UPSIT score; OR = 3.93, 95% CI 1.20–12.88). Given this dramatic boost to OT effectiveness, it is worth examining if this extra OT benefit due to budesonide irrigation would produce a larger cognitive and neurological benefit as well.

Ninth, the psychophysics of odorants should also be considered in future studies. Presumably, the molecular shape, size, or complexity of odorants may produce various benefits on olfactory receptors, creating differential effects on olfaction and cognition. This area is touched upon by the Oleszkiewicz et al.’s (2021) study that examined the impact of “simple” single molecule OT vs more complex multi-molecular odorant mixtures OT on cognition; more complex odorants did not produce greater cognitive or olfactory outcomes. Similarly, Poletti et al. (2017) randomized a sample of 98 adults with posttraumatic and post-viral olfactory loss to receive OT with either five months of light weight molecule odorants (LWM; < 150 g/mol) OT or heavy weight molecule odorants (HWM; > 150 g/mol) OT. Researchers concluded that olfaction improved similarly in both OT groups, with the exception that HWM OT corresponded to a greater odorant threshold improvement in the posttraumatic olfactory loss participants. Similarly, Sinding et al. (2014) examined age-related olfactory sensitivity for light (< 150 g/mol) vs heavy (> 150 g/mol) molecules in normosmic younger and older adults. Researchers found that younger adults were sensitive to both light and heavy molecular odorants but older adults were less sensitive to heavy molecule odorants. This suggests that OT in older adults may require the use of light molecule odorants. This becomes more complex when we consider that with age, people are less sensitive to detect pleasant odors while retaining sensitivity to unpleasant odors (Khan et al., 2007). Moreover, research also shows that the structure of the odor molecular can produce different odorants (e.g., lactones = apricot/coconut smell; volatile fatty acids = rancid/sour smell; esters = fruity smell) (Genva et al., 2019). With these caveats, studies should consider reporting the molecular information of odorants so that OT can eventually be standardized and patterns can be detected in the literature.

A limitation of this systematic review is that we did not conduct a meta-analysis; however, there were several reasons that would have diminished the scientific value of such a meta-analysis at this time. First, the data reflect heterogenous OTs making it difficult, if not impossible, to pool. OTs vary widely by: a) treatment lengths (i.e., days – months), b) amount engaged in each odorant (i.e., sniffing the odorants from 5 s – 30 s each); c) times per day to smell odorants (i.e., not specified, 2x/day, 4x/day); d) number of odorants (i.e., 1 odorant – 40 odorants), and e) types of odorants (i.e., n-butanol, lemon, phenethylamine, simple odorants vs complex odorants). Second, studies included a wide variety of clinical populations (i.e., healthy adults, those with dementia, men with laryngectomy, younger and older adults) and with a range of olfactory abilities (i.e., normosmia, anosmia, hyposmia). Both considerations are problematic because it is unclear how to factor in the effect OT truly has as the effect sizes would vary drastically based on type of population and olfactory ability level. Third, the cognitive/neurological outcomes of OT also vary dramatically as it is not clear how to standardize and combine the neuroimaging and cognitive data into a composite that reflects a single neurological outcome coefficient that can be reliably and validly incorporated into a meta-analysis. Even with just the cognitive data, some studies simply employ a cognitive screener (e.g., MOCA) while others may have a partial or full cognitive battery; and even when certain cognitive domains (e.g., executive function) may be represented in certain studies, the cognitive measures are different. Fourth, treatment fidelity was poorly measured or non-existent in most studies. Thus, it is unclear how much OT participants received. Given these limitations in the OT literature, generating an effect size of OT on neurocognition is not warranted at this time as a statistical value from such a meta-analysis may mischaracterize the true effect. Future studies of OT need to address many of these methodological limitations so that eventually this connection of OT on neurocognitive outcomes, as well as the mediation effect of improved olfaction on such neurocognitive outcomes, be examined with better scientific rigor.

Finally, a limitation of this systematic review is that we did not incorporate all interventions that could improve olfaction. For example, based on a case study, photobiomodulation therapy (i.e., light helmet, body pad, intranasal piece) has been suggested as a way to improve olfaction and cognition (Salehpour et al., 2019). Focusing on OT exclusively in this review was strategic as other types of olfactory intervention may not be as simple to administer as OT, which is also inexpensive and seems face-valid and readily understood by people.

Conclusion

Although not conclusive, the reviewed OT studies on cognition and neuroimaging provided converging evidence that OT improved brain function as exhibited by improved cognitive performance, increased volumes in several brain regions, and increased neural connectivity/efficiency. Albeit, with such small sample sizes, the summary from this systematic review should be drawn cautiously, as sample error and lack of multiple comparison corrections could have played a role in our conclusions. More rigorous research is needed as these studies suffer from small sample sizes which limit generalizability, lack active control groups needed for proper experimental comparisons, used limited cognitive measures to determine their impact across a broad range of cognitive domains, and lack significant long-term follow-up assessment needed to determine robustness of training effects are over time. Despite these limitations, the converging evidence is compelling, clearly showing the potential of OT to improve cognitive and brain function in a range of adults with and without olfactory loss.